These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


84 related items for PubMed ID: 9348227

  • 21. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo.
    Walker EC, Poulton IJ, McGregor NE, Ho PW, Allan EH, Quach JM, Martin TJ, Sims NA.
    J Bone Miner Res; 2012 Apr; 27(4):902-12. PubMed ID: 22190112
    [Abstract] [Full Text] [Related]

  • 22. Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects.
    Betz UA, Bloch W, van den Broek M, Yoshida K, Taga T, Kishimoto T, Addicks K, Rajewsky K, Müller W.
    J Exp Med; 1998 Nov 16; 188(10):1955-65. PubMed ID: 9815272
    [Abstract] [Full Text] [Related]

  • 23. Mechanisms mediating the inhibitory effect of all-trans retinoic acid on primitive hematopoietic stem cells in human long-term bone marrow culture.
    Sammons J, Ahmed N, Khokher MA, Hassan HT.
    Stem Cells; 2000 Nov 16; 18(3):214-9. PubMed ID: 10840075
    [Abstract] [Full Text] [Related]

  • 24. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
    Klein C, Wüstefeld T, Assmus U, Roskams T, Rose-John S, Müller M, Manns MP, Ernst M, Trautwein C.
    J Clin Invest; 2005 Apr 16; 115(4):860-9. PubMed ID: 15761498
    [Abstract] [Full Text] [Related]

  • 25. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
    Nandurkar HH, Hilton DJ, Nathan P, Willson T, Nicola N, Begley CG.
    Oncogene; 1996 Feb 01; 12(3):585-93. PubMed ID: 8637716
    [Abstract] [Full Text] [Related]

  • 26. Reduced expression of the cytokine transducer gp130 inhibits hormone secretion, cell growth, and tumor development of pituitary lactosomatotrophic GH3 cells.
    Castro CP, Giacomini D, Nagashima AC, Onofri C, Graciarena M, Kobayashi K, Páez-Pereda M, Renner U, Stalla GK, Arzt E.
    Endocrinology; 2003 Feb 01; 144(2):693-700. PubMed ID: 12538632
    [Abstract] [Full Text] [Related]

  • 27. New insights into the cellular, biochemical, and molecular basis of postmenopausal and senile osteoporosis: roles of IL-6 and gp130.
    Manolagas SC, Bellido T, Jilka RL.
    Int J Immunopharmacol; 1995 Feb 01; 17(2):109-16. PubMed ID: 7657404
    [Abstract] [Full Text] [Related]

  • 28. Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion.
    Shimon I, Yan X, Ray DW, Melmed S.
    J Clin Invest; 1997 Jul 15; 100(2):357-63. PubMed ID: 9218512
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity.
    Sun RX, Gennaro C, Rocco S, Gu ZJ, Klein B.
    Eur Cytokine Netw; 1997 Mar 15; 8(1):51-6. PubMed ID: 9110148
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders.
    Yoshida K, Taga T, Saito M, Suematsu S, Kumanogoh A, Tanaka T, Fujiwara H, Hirata M, Yamagami T, Nakahata T, Hirabayashi T, Yoneda Y, Tanaka K, Wang WZ, Mori C, Shiota K, Yoshida N, Kishimoto T.
    Proc Natl Acad Sci U S A; 1996 Jan 09; 93(1):407-11. PubMed ID: 8552649
    [Abstract] [Full Text] [Related]

  • 34. gp130 signaling in bone cell biology: multiple roles revealed by analysis of genetically altered mice.
    Sims NA.
    Mol Cell Endocrinol; 2009 Oct 30; 310(1-2):30-9. PubMed ID: 18805458
    [Abstract] [Full Text] [Related]

  • 35. Differential osteoblastic activity in primary metaphyseal trabecular and secondary trabeculae of c-fos deficient mice.
    Yamamoto T, Abe M, Hongo H, Maruoka H, Yoshino H, Haraguchi-Kitakamae M, Udagawa N, Li M, Amizuka N, Hasegawa T.
    J Oral Biosci; 2023 Dec 30; 65(4):265-272. PubMed ID: 37595744
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways.
    Sims NA, Jenkins BJ, Quinn JM, Nakamura A, Glatt M, Gillespie MT, Ernst M, Martin TJ.
    J Clin Invest; 2004 Feb 30; 113(3):379-89. PubMed ID: 14755335
    [Abstract] [Full Text] [Related]

  • 38. Bone marrow dysfunction in mice lacking the cytokine receptor gp130 in endothelial cells.
    Yao L, Yokota T, Xia L, Kincade PW, McEver RP.
    Blood; 2005 Dec 15; 106(13):4093-101. PubMed ID: 16118327
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.